The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study

BackgroundHome spirometers have been widely implemented in the treatment of people with cystic fibrosis (CF). Frequent spirometry measurements at home could lead to earlier detection of exacerbations. However, previous research indicates that the long-term use of home spirome...

Full description

Saved in:
Bibliographic Details
Main Authors: Pia Bertram, Martinus C Oppelaar, Michiel AGE Bannier, Monique HE Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, Lennart Conemans, Bart L Rottier, Marianne Nuijsink, Lara S van den Wijngaart, Peter JFM Merkus, Jolt Roukema
Format: Article
Language:English
Published: JMIR Publications 2025-01-01
Series:Journal of Medical Internet Research
Online Access:https://www.jmir.org/2025/1/e60689
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550889338273792
author Pia Bertram
Martinus C Oppelaar
Michiel AGE Bannier
Monique HE Reijers
Hester van der Vaart
Renske van der Meer
Josje Altenburg
Lennart Conemans
Bart L Rottier
Marianne Nuijsink
Lara S van den Wijngaart
Peter JFM Merkus
Jolt Roukema
author_facet Pia Bertram
Martinus C Oppelaar
Michiel AGE Bannier
Monique HE Reijers
Hester van der Vaart
Renske van der Meer
Josje Altenburg
Lennart Conemans
Bart L Rottier
Marianne Nuijsink
Lara S van den Wijngaart
Peter JFM Merkus
Jolt Roukema
author_sort Pia Bertram
collection DOAJ
description BackgroundHome spirometers have been widely implemented in the treatment of people with cystic fibrosis (CF). Frequent spirometry measurements at home could lead to earlier detection of exacerbations. However, previous research indicates that the long-term use of home spirometry is not well maintained by people with CF. ObjectiveWe aimed to gain insight into the long-term uptake of home spirometry in regular multicenter CF care. MethodsHome spirometers combined with a remote monitoring platform were introduced in the treatment of people with CF in 5 Dutch CF centers starting in April 2020. Usage data from April 2020 to December 2022 were analyzed retrospectively. Survival analyses were conducted to assess use consistency over time, and t tests were used to evaluate the impact of increased pulmonary symptoms on home spirometry frequency. The effect of the initiation of a new treatment, Elexacaftor/Tezacaftor/Ivacaftor, on use frequency over time was assessed in a subgroup of participants with repeated measures ANOVA. ResultsDuring the observation period, a total of 604 people with CF were enrolled in the remote monitoring platform and 9930 home spirometry measurements were performed. After the initiation of home spirometry use, the number of users declined rapidly. One year after the initiation, 232 (54.2%) people with CF stopped using home spirometry. During the observation period, 67 (11.1%) users performed more than 20 measurements. Furthermore, the number of consistent home spirometry users decreased over time. After 600 days, only 1% of users had measured their lung function consistently every 31 days. Use frequency slightly increased during periods with increased pulmonary symptoms (ΔMean=0.45, t497.278=–4,197; P<.001) and showed an initial rise followed by a decrease after starting treatment with Elexacaftor/Tezacaftor/Ivacaftor (ΔMean=0.45, t497.278=–4,197; P<.001). ConclusionsConsistent uptake of home spirometry in people with CF is low but increases around periods of changing symptoms. A clear strategy for the organization of remote care seemed to improve the long-term uptake of home spirometry. Nevertheless, home spirometry and its intensity are not a goal on their own but should be used as a tool to reach individual goals within local contexts.
format Article
id doaj-art-fed9d019a1b34a9ea59cc87a0f5cc456
institution Kabale University
issn 1438-8871
language English
publishDate 2025-01-01
publisher JMIR Publications
record_format Article
series Journal of Medical Internet Research
spelling doaj-art-fed9d019a1b34a9ea59cc87a0f5cc4562025-01-09T22:00:29ZengJMIR PublicationsJournal of Medical Internet Research1438-88712025-01-0127e6068910.2196/60689The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational StudyPia Bertramhttps://orcid.org/0009-0002-4902-5877Martinus C Oppelaarhttps://orcid.org/0000-0002-8051-4161Michiel AGE Bannierhttps://orcid.org/0000-0003-4823-5872Monique HE Reijershttps://orcid.org/0000-0002-4401-5103Hester van der Vaarthttps://orcid.org/0009-0006-8755-2466Renske van der Meerhttps://orcid.org/0000-0003-1818-6360Josje Altenburghttps://orcid.org/0000-0002-7248-963XLennart Conemanshttps://orcid.org/0000-0002-2348-1826Bart L Rottierhttps://orcid.org/0000-0002-2437-8070Marianne Nuijsinkhttps://orcid.org/0000-0002-3948-2794Lara S van den Wijngaarthttps://orcid.org/0000-0002-4197-371XPeter JFM Merkushttps://orcid.org/0000-0002-1977-7384Jolt Roukemahttps://orcid.org/0000-0001-6971-7892 BackgroundHome spirometers have been widely implemented in the treatment of people with cystic fibrosis (CF). Frequent spirometry measurements at home could lead to earlier detection of exacerbations. However, previous research indicates that the long-term use of home spirometry is not well maintained by people with CF. ObjectiveWe aimed to gain insight into the long-term uptake of home spirometry in regular multicenter CF care. MethodsHome spirometers combined with a remote monitoring platform were introduced in the treatment of people with CF in 5 Dutch CF centers starting in April 2020. Usage data from April 2020 to December 2022 were analyzed retrospectively. Survival analyses were conducted to assess use consistency over time, and t tests were used to evaluate the impact of increased pulmonary symptoms on home spirometry frequency. The effect of the initiation of a new treatment, Elexacaftor/Tezacaftor/Ivacaftor, on use frequency over time was assessed in a subgroup of participants with repeated measures ANOVA. ResultsDuring the observation period, a total of 604 people with CF were enrolled in the remote monitoring platform and 9930 home spirometry measurements were performed. After the initiation of home spirometry use, the number of users declined rapidly. One year after the initiation, 232 (54.2%) people with CF stopped using home spirometry. During the observation period, 67 (11.1%) users performed more than 20 measurements. Furthermore, the number of consistent home spirometry users decreased over time. After 600 days, only 1% of users had measured their lung function consistently every 31 days. Use frequency slightly increased during periods with increased pulmonary symptoms (ΔMean=0.45, t497.278=–4,197; P<.001) and showed an initial rise followed by a decrease after starting treatment with Elexacaftor/Tezacaftor/Ivacaftor (ΔMean=0.45, t497.278=–4,197; P<.001). ConclusionsConsistent uptake of home spirometry in people with CF is low but increases around periods of changing symptoms. A clear strategy for the organization of remote care seemed to improve the long-term uptake of home spirometry. Nevertheless, home spirometry and its intensity are not a goal on their own but should be used as a tool to reach individual goals within local contexts.https://www.jmir.org/2025/1/e60689
spellingShingle Pia Bertram
Martinus C Oppelaar
Michiel AGE Bannier
Monique HE Reijers
Hester van der Vaart
Renske van der Meer
Josje Altenburg
Lennart Conemans
Bart L Rottier
Marianne Nuijsink
Lara S van den Wijngaart
Peter JFM Merkus
Jolt Roukema
The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
Journal of Medical Internet Research
title The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
title_full The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
title_fullStr The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
title_full_unstemmed The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
title_short The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study
title_sort long term uptake of home spirometry in regular cystic fibrosis care retrospective multicenter observational study
url https://www.jmir.org/2025/1/e60689
work_keys_str_mv AT piabertram thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT martinuscoppelaar thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT michielagebannier thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT moniquehereijers thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT hestervandervaart thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT renskevandermeer thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT josjealtenburg thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT lennartconemans thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT bartlrottier thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT mariannenuijsink thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT larasvandenwijngaart thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT peterjfmmerkus thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT joltroukema thelongtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT piabertram longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT martinuscoppelaar longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT michielagebannier longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT moniquehereijers longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT hestervandervaart longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT renskevandermeer longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT josjealtenburg longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT lennartconemans longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT bartlrottier longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT mariannenuijsink longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT larasvandenwijngaart longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT peterjfmmerkus longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy
AT joltroukema longtermuptakeofhomespirometryinregularcysticfibrosiscareretrospectivemulticenterobservationalstudy